ANGPTL8 expression in the liver has also been observed to be higher in multiple mouse models of fatty liver, suggesting that ANGPTL8 could be a potential biomarker for NAFLD [32]. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.